Abstract
Background: Receptor-activating autoantibodies are associated with various cardiovascular diseases. Results: A human monoclonal autoantibody isolated from a patient with idiopathic postural hypotension activates the β2-adrenergic receptor and induces potent vasodilatation. Conclusion: This antibody demonstrates sufficient activity to produce postural hypotension in its host. Significance: This is the first human monoclonal autoantibody that activates an autonomic receptor. © 2013 by The American Society for Biochemistry and Molecular Biology, Inc.
Cite
CITATION STYLE
Li, H., Zuccolo, J., Kem, D. C., Zillner, C., Lee, J., Smith, K., … Yu, X. (2013). Implications of a vasodilatory human monoclonal autoantibody in postural hypotension. Journal of Biological Chemistry, 288(42), 30734–30741. https://doi.org/10.1074/jbc.M113.477869
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.